New User:

Forgot your password?

Stock Market & Financial Investment News

Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 >>
November 23, 2015
13:34 EDTTAT&T, A+E Networks reach multi-year distribution agreement
AT&T (T) said in a statement: "AT&T and A+E Networks have signed a long-term, multi-platform distribution agreement, continuing their long-standing relationship. The new agreement delivers to AT&T terms that reflect its new scale and status as the largest pay TV provider in the world." The renewal includes a comprehensive deal that includes linear, TVE, VOD and mobility for the suite of A+E Networks' channels, among the top brands in the media landscape, including: A&E, Lifetime, HISTORY, LMN, FYI and HISTORY en Espanol. In addition, AT&T will launch VICELAND, replacing H2, as part of the A+E Networks' portfolio. A+E Networks said in a statement: "We have worked together with AT&T for many years and we are delighted that this renewal will allow us to do so well into the future. We are thrilled that AT&T's valued customers will be able to enjoy A+E Networks' award-winning portfolio of brands- including A&E, Lifetime, HISTORY, LMN, FYI and HISTORY en Espanol - across their multiple platforms, and that VICELAND's new 24-hour channel will be part of that offering." A+E Networks, LLC. is a joint venture of Disney-ABC Television Group (DIS) and Hearst Corporation.
10:25 EDTKOCoca-Cola management to meet with Bernstein
Meeting to be held in Atlanta on November 30 hosted by Bernstein.
09:39 EDTFBActive equity options trading on open
Subscribe for More Information
09:00 EDTVChase Visa cardholders can now use Samsung Pay
Subscribe for More Information
08:20 EDTIBMMerge Healthcare, eviCore partner to streamline medical imaging process
Subscribe for More Information
07:18 EDTJAHJarden should be bought on recent weakness, says RBC Capital
After viewing a presentation by Jarden's management, RBC Capital thinks the company's organic revenue growth remains on track to accelerate this quarter. The firm continues to believe that the company's fiscal 2016 EPS guidance is conservative, partly due to the impact of cost cutting at the company's Brazil unit. The firm keeps a $60 price target and Outperform rating on the name.
05:58 EDTTAT&T implied volatility of 14 at lower end of index mean range
November 22, 2015
19:37 EDTYHOOTop Yahoo media executive leaves company, Re/code says
Subscribe for More Information
17:05 EDTFBFacebook CEO Zuckerberg to take two months paternity leave
Facebook CEO Mark Zuckerberg stated in a social media posting that he will take two months of paternity leave when his daughter is born. Reference Link
November 20, 2015
18:05 EDTINTCIntel names Dr. Venkata Renduchintala as President of newly created IoT group
Subscribe for More Information
16:02 EDTINTC, FBOptions Update; November 20, 2015
Subscribe for More Information
11:13 EDTINTCIntel, semi equipment stocks rise following chip giant's guidance
Intel (INTC) is climbing after the chip maker said at its analyst day meeting yesterday that it expects its revenue to grow by a mid-single digit percentage in fiscal 2016, up from a decline of 1% this year. On the heels of yesterday's meeting, research firm JMP Securities upgraded its rating on the stock to Outperform, saying that the company's margins and revenue are poised to climb next year. WHAT'S NEW: After conducting checks at a trade show and investor event, JMP Securities analyst Alex Gauna wrote that Intel's outlook in the cloud has improved, while its execution risk has dropped. Discussing Intel's outlook in the server chip market, Gauna wrote that the tech giant "has made significant strides" with its Xeon, Xeon Phi and Atom chips, even as rival ARM-based servers are growing more slowly than expected. Moreover, Intel is benefiting from the strong performance of its 2-in-1 notebooks, data center offerings, and enterprise PCs, Gauna reported. He believes that the chip maker's earnings are bottoming, while its revenue and margins are poised to rebound next year. Gauna raised his fiscal 2016 earnings per share estimate for the company to $2.45 from $2.10. Analysts' consensus estimate is $2.35. Gauna set a $45 price target on Intel. WHAT'S NOTABLE: Noting that Intel had predicted that its capital spending would jump 37% in 2016, KeyBanc said that this news is positive for semiconductor equipment stocks. According to the firm, Applied Materials (AMAT), Lam Research (LRCX) and Nanometrics (NANO) all have high exposure to Intel. It recommended that investors buy those stocks. PRICE ACTION: In late morning trading, Intel advanced 2% to $35, while Applied Materials rose fractionally, Lam Research gained 0.8%, Nanometrics added 1.7% and Rudolph Technologies (RTEC) jumped 4%.
10:04 EDTINTC, FBActive equity options trading on open
Subscribe for More Information
10:00 EDTIBMOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Acceleron (XLRN) initiated with an Outperform at Oppenheimer... CSRA (CSRA) initiated with an Outperform at Cowen... HP Enterprise (HPE) initiated with a Neutral at Baird... Hortonworks (HDP) initiated with a Buy at Needham... IBM (IBM) initiated with an Outperform at JMP Securities... ITC Holdings (ITC) initiated with a Buy at Citi... Sucampo (SCMP) initiated with a Hold at Jefferies.
10:00 EDTINTCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: (FLWS) upgraded to Buy from Hold at Noble Financial... Diageo (DEO) upgraded to Overweight from Neutral at JPMorgan... Dollar General (DG) upgraded to Buy from Hold at BB&T... Intel (INTC) upgraded on positive checks at JMP Securities... Mazor Robotics (MZOR) upgraded to Buy from Neutral at Sterne Agee CRT... Star Bulk Carriers (SBLK) upgraded to Neutral from Sell at UBS... Trimble (TRMB) upgraded to Buy from Neutral at Goldman.
07:22 EDTINTCIntel upgraded on positive checks at JMP Securities
As noted earlier, JMP Securities upgraded Intel to Outperform from Market Perform. After conducting checks, the firm thinks the company is benefiting from strengthening cloud prospects and diminishing execution risk. JMP believes that Intel has made significant progress on server chips, is in the midst of an earnings trough, and is poised to reported higher revenue and margins in 2016. Target $45.
07:21 EDTINTCIntel confident of sales growth despite PC chip sales decline, says UBS
UBS came away from Intel's analyst meeting believing the company is confident it can continue to grow sales despite declining PC chip sales. The firm cited expectations for continued growth of data center sales and better than expected operating expense management. UBS reiterated its Buy rating and raised its price target to $39 from $37 on Intel shares.
07:13 EDTIBMIBM initiated with an Outperform at JMP Securities
JMP Securities analyst Greg McDowell initiated IBM with an Outperform rating and $167 price target on shares. McDowell believes sentiment is too negative and investors do not appreciate its leadership position in multiple technology categories and sticky customer base, the potential for a crossover point within the next two years, when the fast-growing revenue components of the business will offset declines in the more mature businesses, its revenue diversity, with software now a significant portion of revenue and hardware less, and its capacity for self-renewal.
06:18 EDTINTCIntel upgraded to Outperform from Market Perform at JMP Securities
Subscribe for More Information
November 19, 2015
16:23 EDTINTCOn The Fly: Top stock stories for Thursday
The major averages spent most of the day in a narrow range bouncing around the flatline, seeming content to consolidate the gains from their rally of the last three days. The market internals confirmed the lackluster session, as the number of advancing stocks were generally in line with declining stocks. Oil prices remained under pressure for much of the session, but closed the day little changed, similar to equities. ECONOMIC EVENTS: In the U.S., jobless claims are still near four-decade lows, with 271,000 first-time claims filed in the week ended November 14. The Philly Fed index rose 6.4 points to 1.9 in November, better than the forecast for a -0.5 reading. In Europe, minutes from the most recent European Central Bank policy meeting showed that some participants called for more stimulus amid deflation risks, weak oil prices and a sluggish recovery in the regions' economy. In Asia, the Bank of Japan maintained its current pace of monetary stimulus, as expected. COMPANY NEWS: The biggest U.S. health insurer said this morning that it is considering pulling out of Obamacare due to losses it has suffered from its participation in the program and cut its profit outlook for this fiscal year, sending its shares and those of its industry peers lower. UnitedHealth (UNH) fell $6.62, or 5.65%, to $110.63 after trimming its fiscal 2015 earnings outlook, citing the Affordable Care Act, and stating that it is "evaluating the viability of the insurance exchange product segment." Meanwhile, Aetna (AET) declined 6.5%, Humana (HUM) dropped 4%, Anthem (ANTM) declined almost 7% and Cigna (CI) slid over 5% following their rival's announcement. Hospital stocks fell as well, with HCA Holdings (HCA), LifePoint (LPNT), Community Health (CYH) and Tenet (THC) all ending the day lower by 6% or more... Last night, Bloomberg reported that Pfizer (PFE) is nearing an agreement to acquire Allergan (AGN) for $370 to $380 per share, citing people familiar with the matter. CNBC's David Faber then reported that deal talks are in the "final innings" and centered on an all stock transaction whereby Pfizer would offer 11-plus shares per Allergan share. Then, people close to the talks told Financial Times that the U.S. drugmaker is preparing to offer more than $380 per share for Allergan. Amid all these reports, Treasury Secretary Jacob Lew said that his department will release "targeted guidance" later this week meant to "deter and reduce further the economic benefits of corporate inversions" like the one being contemplated by the drugmakers. Government intervention concerns appeared to trump the pricing reports, as Allergan closed the day 2.8% lower at $301.73, while Pfizer fell 3% to $32.29 per share... Intel (INTC) rose 3.4% to $34.30 after the chipmaking giant hosted its annual investor meeting, at which it announced an increase to its dividend and guided for "mid-single digits" percentage revenue growth in fiscal 2016. MAJOR MOVERS: Among the notable gainers was Keurig Green Mountain (GMCR), which surged $7.38, or 18.22%, to $47.88 after it reported better than expected quarterly earnings and guided for fiscal 2016. Also higher was Square (SQ), which rose $4.07, or 45%, to close its first day as a publicly-traded company at $13.07 after pricing its initial public offering at $9 per share. Twitter (TWTR), which, like Square, claims Jack Dorsey as its CEO, gained 1.6% to $26.32 following Square's public debut. Another high-profile tech company also gained in its first day of public trading, as Match Group (MTCH), the owner of dating app Tinder and other online dating services, climbed 22.8% to $14.74 after pricing its IPO at $12 per share. Among the noteworthy losers was Kirkland's (KIRK), which fell nearly 33% to $13.60 after the company reported downbeat quarterly earnings and provided lower than expected guidance. Also lower were shares of AMAG Pharmaceuticals (AMAG), which lost 9.84% to $26.20 after it received a complete response letter from the FDA for its proposed treatment to reduce the risk of preterm birth in at-risk patients. INDEXES: The Dow fell 4.41, or 0.02%, to 17,732.75, the Nasdaq slid 1.56, or 0.03%, to 5,073.64, and the S&P 500 declined 2.34, or 0.11%, to 2,081.24.
<< 1 | 2 | 3 | 4 | 5 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use